ORLANCE Trademark

Trademark Overview


On Wednesday, February 3, 2021, a trademark application was filed for ORLANCE with the United States Patent and Trademark Office. The USPTO has given the ORLANCE trademark a serial number of 90507936. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, June 20, 2024. This trademark is owned by Orlance, Inc.. The ORLANCE trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Vaccines; vaccine preparations; medical preparations for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; pharmaceutical preparations and substances for the treatment of diseases and disorders, namely, autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; chemical preparations for the treatment of diseases affecting mucosal tissues, the immune system, and respiratory tissues; chemical preparations for pharmaceutical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; chemical preparations for medical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer

Medical services; medical testing for treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical evaluation services of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; medical treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer

Medical devices to treat autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; medical devices for administering vaccines pneumatically and parts thereof; vaccine apparatus comprised of devices for administering vaccines pneumatically; vaccine apparatus, namely, automatic vaccination apparatus

Research and development of vaccines; research and development of medicines, namely pharmaceutical research and development; research and development in the field of vaccination apparatus; medical research; scientific research; clinical research in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy, immune-oncology, chemotherapy, and anti-tumor agents
orlance

General Information


Serial Number90507936
Word MarkORLANCE
Filing DateWednesday, February 3, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, June 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2022

Trademark Statements


Goods and ServicesVaccines; vaccine preparations; medical preparations for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; pharmaceutical preparations and substances for the treatment of diseases and disorders, namely, autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; chemical preparations for the treatment of diseases affecting mucosal tissues, the immune system, and respiratory tissues; chemical preparations for pharmaceutical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; chemical preparations for medical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer
Goods and ServicesMedical services; medical testing for treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical evaluation services of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; medical treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer
Goods and ServicesMedical devices to treat autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; medical devices for administering vaccines pneumatically and parts thereof; vaccine apparatus comprised of devices for administering vaccines pneumatically; vaccine apparatus, namely, automatic vaccination apparatus
Goods and ServicesResearch and development of vaccines; research and development of medicines, namely pharmaceutical research and development; research and development in the field of vaccination apparatus; medical research; scientific research; clinical research in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy, immune-oncology, chemotherapy, and anti-tumor agents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, May 6, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 6, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 6, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOrlance, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98104

Party NameOrlance, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98104

Trademark Events


Event DateEvent Description
Saturday, February 6, 2021NEW APPLICATION ENTERED
Thursday, May 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 25, 2021ASSIGNED TO EXAMINER
Thursday, August 26, 2021NON-FINAL ACTION WRITTEN
Thursday, August 26, 2021NON-FINAL ACTION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 23, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 25, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, March 25, 2022EXAMINERS AMENDMENT E-MAILED
Friday, March 25, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 25, 2022EXAMINER'S AMENDMENT ENTERED
Friday, March 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, March 27, 2022ASSIGNED TO LIE
Wednesday, April 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 3, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 3, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 21, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 21, 2022SOU EXTENSION 1 FILED
Wednesday, December 21, 2022SOU EXTENSION 1 GRANTED
Friday, December 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 20, 2023SOU EXTENSION 2 FILED
Tuesday, June 20, 2023SOU EXTENSION 2 GRANTED
Thursday, June 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 19, 2023SOU EXTENSION 3 FILED
Tuesday, December 19, 2023SOU EXTENSION 3 GRANTED
Thursday, December 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2024SOU EXTENSION 4 FILED
Thursday, June 20, 2024SOU EXTENSION 4 GRANTED